Purchase Order 80NSSC23PB390

Award Date 8/3/23
Potential Completion Date 2/2/24
Potential Value $150K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Monrovia, CA 91016, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
500
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The U.S. government has awarded a Small Business Innovation Research (SBIR) Phase II contract worth $846,741.00 to Chromologic LLC, a minority-owned, for-profit limited liability company, to develop the "Microorganisms Genome Enrichment and Amplification Sequencing (MGEAS)" technology. This Firm Fixed Price contract was awarded by the Shared Services Center, a civilian agency, with a completion date of June 13, 2026. Chromologic is a manufacturer of goods and has a strong track...
This is a U.S. government contract awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Small Business Innovation Research (SBIR) Phase I project. The contract, valued at $167,497.00, is a firm fixed-price purchase order set aside for small businesses. The contract supports research and development activities in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures, leveraging Chromologic's expertise in biomedical engineering,...
This federal contract award, valued at $299,914.00, was granted to Chromologic LLC, a minority-owned, for-profit limited liability company, by the National Institute of Allergy and Infectious Diseases, a civilian agency. The contract, which is a Definitive Contract with a Firm Fixed Price pricing type, is for the SBIR 134 - CHROMOLOGIC project. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2025. Chromologic is a manufacturer of goods that...
This contract award is for a Small Business Innovation Research (SBIR) Phase II project awarded by the Department of the Navy's Office of Naval Research to Chromologic LLC, a minority-owned limited liability company that conducts research and development across various federal agencies. The $1,999,834.00 award is for a Cost Plus Fixed Fee type contract with a completion date of December 14, 2027. As an SBIR Phase II effort, this contract builds upon prior SBIR Phase I work conducted by...
The U.S. Army awarded a firm-fixed-price purchase order contract to Chromologic LLC, a minority-owned small business, for a Phase I Small Business Innovation Research (SBIR) project titled "Phase I Probabilistic Analysis for Next Generation Sequencing (PANGS)." The $167,450.97 contract was awarded on August 10, 2020, with an ultimate completion date of August 9, 2021. The contract is a total small business set-aside, indicating that it is reserved exclusively for small businesses....
This federal contract award was made by the Department of the Navy Naval Air Systems Command Naval Air Warfare Center to Chromologic LLC, doing business as Chromologic, a minority-owned, for-profit limited liability company that provides research, development, and manufacturing services. The contract is a Small Business Innovation Research (SBIR) Phase I award with a firm fixed price of $239,927.00 and a completion date of January 18, 2022. Chromologic has previously received SBIR and Small...
This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Chromologic LLC, doing business as Chromologic, a minority-owned small business. The $299,980.00 Firm Fixed Price contract is for the development of a "Highly-Efficient Isolation and Fidelity Differentiation of Exosomes (HIFIDE) from Bodily Fluids Kit" under the Small Business Innovation Research (SBIR) program. Chromologic has...
This contract is a Small Business Innovation Research (SBIR) Phase II award to Chromologic LLC, a minority-owned, for-profit limited liability company. The $1,099,984.00 cost-plus-fixed-fee contract was awarded by the Naval Air Warfare Center for research and development of innovative technologies. As a total small business set-aside, this award supports Chromologic's expertise in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures. The company has a strong track...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Chromologic LLC, a minority-owned, for-profit limited liability company. The $149,950.07 Firm Fixed Price contract is for the development of an "Automated, High Throughput, Microfluidic Assembly and Transfer of Synthetic Genomes (SynGen System)". The contract has a total small business set-aside designation. Chromologic is a manufacturer of...
This award is for a $1,074,903.98 Firm Fixed Price contract under the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) program. The contract was awarded to Chromologic LLC, a minority-owned small business, for the development of a Phase II project titled "In-Line, Non-Invasive, Non-Destructive Cell Monitoring in Dynamically Growing Cultures". The project was solicited under DHA SBIR Topic DHA18-006, and the work is to be performed in Monrovia, California....

This federal contract award, with an ID of 80NSSC23PB390, was issued by the Shared Services Center, a civilian agency, to Chromologic LLC, a minority-owned small business, for a Small Business Innovation Research (SBIR) Phase I project titled "Microorganisms Genome Enrichment and Amplification Sequencing (MGEAS)". The contract, with a firm fixed price of $149,918.00 and a completion date of February 2, 2024, is designated as a total small business set-aside. The project aims to develop innovative technologies related to medical devices, pharmaceuticals, diagnostics, and countermeasures, which aligns with the agency's high-level programs focused on advancing scientific and technological capabilities.

Generated 8/21/24, 7:12 PM